Patent applications and USPTO patent grants for PROTEXEON LIMITED.The latest application filed is for "use of xenon as neuroprotectant in a neonatal subject".
Patent | Date |
---|---|
Use Of Xenon As Neuroprotectant In A Neonatal Subject App 20090311340 - Franks; Nicholas Peter ;   et al. | 2009-12-17 |
Analgesic agent for newborn or fetal subjects Grant 7,632,872 - Franks , et al. December 15, 2 | 2009-12-15 |
Use of xenon for the control of neurological deficits associated with cardiopulmonary bypass Grant 7,442,383 - Franks , et al. October 28, 2 | 2008-10-28 |
Use of xenon with hypothermia for treating neonatal asphyxia Grant 7,390,508 - Franks , et al. June 24, 2 | 2008-06-24 |
Use of xenon with hypothermia for treating neonatal asphyxia App 20070104796 - Franks; Nicholas Peter ;   et al. | 2007-05-10 |
NMDA antagonist comprising xenon Grant 6,653,354 - Franks , et al. November 25, 2 | 2003-11-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.